List of Authors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
List of Authors
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
T. De Beer
Toyohiko Takeda
Michelle Talley
Mesbah Uddin Talukder
Charles Y. Tan
Z. Jessica Tan
Minako Tanaka
Jeremy Tanner
Klaus Tarrach
Randy Tatlock
Billy Tauzin
Charlotte Taylor
James Taylor
John Taylor
Julian Taylor
Phil Taylor
Stephen Taylor
Stability Expert Teams
Aptean
Andrew Teasdale
Agilent Technologies
Videojet Technologies Inc.
Freeman Technology
OBK Technology
Mauli Teli
Peter Tell
Allen C. Templeton, PhD
Allen C. Templeton
Jim Tennermann
Alex Terentiev
Eden Tesfu, Ph.D.
Paul A. Tetley
Cameron Tew
Don L. Theis
MicroThermics
Jacques Thilly
Uwe Thissen
Michael Thomas
Robert J. Thomas
Saji Thomas
Harry Thomason
Duncan Thompson
Ian Thompson
Michael R. Thompson
T.N. Thompson
Tracy Thurkow
Robert J. Timko
Jozef H. Timmermans
Robert Timpano
Robert J. Timpano
Steliyan Tinkov
Graham Tinsley
John H. Tipping
Vern Tisdale
David Tisi
Sandip B. Tiwari
Rowel Tobias
Sergej Toedtli
Ian Toledo de Zayas
Gaurav T. Tolia
Nick Toltl, PhD
Piero Tomasi
M.S, Tomassone
Karla Tombaugh
Cheng Tong
Amelia Tope
Lynn D. Torbeck
Adrijana Torbovska
Gregor Toschkoff
Terrence Tougas
Michael D. Tousey
Suzana Trajkovic-Jolevska
Andrew Tran
Chuck Treutel
Namrata R. Trivedi
Mark D. Trone
A. Mark Trotter
Michael P. Trova, Ph.D.
J. Troxell
Keith Truman
Paul K.S. Tsang
Paul Tsang
Shinichiro Tsue
Erica J. Tullo
Dr. Erica J. Tullo
Liam Tully
Mark Tuomenoska
Mark Turnbull
Neil Turner
Graham Tyers
Daniel Tykal
Stephen Tyler
Kim Tyndall
Back to Top

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here